Antimicrobial use: risk driver of multidrug resistant microorganisms in healthcare settings
- 1 August 2009
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Infectious Diseases
- Vol. 22 (4), 352-358
- https://doi.org/10.1097/qco.0b013e32832d52e0
Abstract
PURPOSE OF REVIEW:ud ud This review explores recent evidence on the association between antibiotics usage and resistance.ud RECENT FINDINGS:ud ud A meta-analysis showed that the risk of acquiring methicillin-resistant Staphylococcus aureus was increased by 1.8-fold in patients who had taken antibiotics. Such risk was almost three-times greater after using quinolones or glycopeptides. Significant heterogeneity between studies was mainly related to study designs. A Cochrane systematic review suggested that, although the quality of the evidence was poor, interventions to improve hospital antibiotic prescribing were associated with a reduction in the incidence of antimicrobial resistant pathogens. Against this evidence, mupirocin-resistant S. aureus and linezolid-resistant vancomycin-resistant enterococci (VRE) were detected in institutions where these drugs were not widely used. Studies assessing the impact of vancomycin prescribing restriction on VRE rates were heterogeneous and the effectiveness of such interventions remains poorly defined. Important confounders of studies, other than study design, are the lack of analysis of secular trends of infections, colonization pressure in the ward and duration of follow up.ud SUMMARY:ud ud Available evidence, although not always of high quality, suggests that a link between antibiotics usage at individual and institutional levels and resistant bacteria does exist. Benchmark guidelines for empiric therapy in hospitalized patients, taking into consideration not only patients' needs but also ecological costs of resistance, should be rapidly developedKeywords
This publication has 44 references indexed in Scilit:
- Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complexJournal of Antimicrobial Chemotherapy, 2008
- Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: a time-series analysisJournal of Antimicrobial Chemotherapy, 2008
- Risk factors associated with the isolation of colistin-resistant Gram-negative bacteria: A matched case-control studyCritical Care Medicine, 2008
- Risk-factors for emerging bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coliClinical Microbiology & Infection, 2008
- Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysisJournal of Antimicrobial Chemotherapy, 2007
- Investigating the association between antibiotic use and antibiotic resistance: impact of different methods of categorising prior antibiotic useInternational Journal of Antimicrobial Agents, 2006
- Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused byStaphylococcus aureusNew England Journal of Medicine, 2006
- Current Trends in the Epidemiology of Nosocomial Bloodstream Infections in Patients with Hematological Malignancies and Solid Neoplasms in Hospitals in the United StatesClinical Infectious Diseases, 2003
- The Association Between Antecedent Vancomycin Treatment and Hospital-Acquired Vancomycin-Resistant EnterococciArchives of Internal Medicine, 1999
- Increased expression of fibronectin-binding proteins by fluoroquinolone-resistant Staphylococcus aureus exposed to subinhibitory levels of ciprofloxacinAntimicrobial Agents and Chemotherapy, 1997